A small number of giant health care conglomerates dominate the health care system – that means your pharmacy benefit managers (PBMs) and insurers are often the same company.
Barries to Access are Worsening
When massive health care conglomerates own the PBM and insurer, they can control which medicines are covered, what patients pay, and where they can fill their prescriptions. As a result patients can face higher costs, fewer choices, and delays in care.
In fact:
This isn’t just about cost – it’s also about quality of life for patients. When PBMs limit access to vital medicines, patients may experience delays, disruptions, and negative health impacts.
“Medications I had been taking for over 20 years, they [my insurer] said no, you can’t take that now.”
— Fred, patient advocate
For patients and families facing serious illness in need of medications, those obstacles can make an already difficult journey even harder.
“I spend a lot of hours on the phone talking to these insurance companies to try and have them give me another inhaler that can possibly save my life. It makes me feel that the insurance companies aren’t thinking about us and that they’re just thinking about the profit that they’re making on the medicines.”
— Renee, patient advocate
While some denials are eventually overturned, the process often creates delays, administrative burdens, and disruptions to treatment. For too many patients, these barriers result in delays or abandoned care altogether
Clear, targeted changes can bring greater accountability to PBMs and relief for patients.